Over-expression of hepatocyte growth factor/scatter factor (HGF/SF) and the HGF/SF receptor (cMET) are associated with a high risk of metastasis and recurrence for children and young adults with papillary thyroid carcinoma-Reference-Cited by-同舟云学术

Over-expression of hepatocyte growth factor/scatter factor (HGF/SF) and the HGF/SF receptor (cMET) are associated with a high risk of metastasis and recurrence for children and young adults with papillary thyroid carcinoma

Published:2000-11-17 Issue:5 Volume:53 Page:635-644
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:Clinical Endocrinology

Author:

Ramirez Raul,Hsu Daniel,Patel Aneeta,Fenton Cydney,Dinauer Catherine,Tuttle R. Michael,Francis Gary L.

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1046/j.1365-2265.2000.01124.x/fullpdf

Reference50 articles.

1. Negative/low expression of the met/hepatocyte growth factor receptor identifies papillary thyroid carcinomas with high risk of distant metastases;Belfiore;Journal of Clinical Endocrinology and Metabolism,1997

2. High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma;Bongarzone;Oncogene,1989

3. RET oncogene puzzle in Chernobyl thyroid tumours;Bonn;Lancet,1996

4. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product;Bottaro;Science,1991

5. a comparison of different staging systems predictability of patient outcome. Thyroid carcinoma as an example;Brierley;Cancer,1997

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Basis and Natural History of Medullary Thyroid Cancer: It is (Almost) All in the RET;Cancers;2023-10-05

2. The hepatocyte growth factor/mesenchymal epithelial transition factor axis in high-risk pediatric solid tumors and the anti-tumor activity of targeted therapeutic agents;Frontiers in Pediatrics;2022-08-10

3. DIO3OS as a potential biomarker of papillary thyroid cancer;Pathology - Research and Practice;2022-01

4. Development of metastatic poorly differentiated thyroid cancer from a sub-centimeter papillary thyroid carcinoma in a young patient with a germline MET mutation – association or random chance?;Thyroid Research;2021-08-14

5. Targeting c-Met and AXL Crosstalk for the Treatment of Hepatocellular Carcinoma;Liver Cancer in the Middle East;2021